Ganoderma lucidum: A Potent Pharmacological Macrofungus
Ganoderma lucidum: мощный лекарственный макрогриб
2009-11-29
SCID: 54.1/zep5pd7s
Discuss with AI
Ganoderma lucidumbioactive compoundsmedicinal mushroom cultivationpharmacological effectstriterpenoids and polysaccharides
Figures from the paper
Abstract (AI)
Ganoderma lucidum (Ling Zhi) is a basidiomycete white rot macrofungus which has been used extensively as "the mushroom of immortality" in China, Japan, Korea and other Asian countries for 2000 years. A great deal of work has been carried out on therapeutic potential of Ganoderma lucidum. The basidiocarp, mycelia and spores of Ganoderma lucidum contain approximately 400 different bioactive compounds, which mainly include triterpenoids, polysaccharides, nucleotides, sterols, steroids, fatty acids, proteins/peptides and trace elements which has been reported to have a number of pharmacological effects including immunomodulation, anti-atherosclerotic, anti-inflammatory, analgesic, chemo-preventive, antitumor, chemo and radio protective, sleep promoting, antibacterial, antiviral (including anti-HIV), hypolipidemic, anti-fibrotic, hepatoprotective, anti-diabetic, anti-androgenic, anti-angiogenic, anti-herpetic, antioxidative and radical-scavenging, anti-aging, hypoglycemic, estrogenic activity and anti-ulcer properties. Ganoderma lucidum has now become recognized as an alternative adjuvant in the treatment of leukemia, carcinoma, hepatitis and diabetes. The macrofungus is very rare in nature rather not sufficient for commercial exploitation for vital therapeutic emergencies, therefore, the cultivation on solid substrates, stationary liquid medium or by submerged cultivation has become an essential aspect to meet the driving force towards the increasing demands in the international market. Present review focuses on the pharmacological aspects, cultivation methods and bioactive metabolites playing a significant role in various therapeutic applications.
Key Findings
1
Because wild Ganoderma lucidum is rare and insufficient for commercial therapeutic demand, solid-substrate, stationary-liquid, and submerged cultivation methods are essential for production.
2
Extracts and constituents of Ganoderma lucidum have been reported to exhibit diverse pharmacological activities, including immunomodulatory, anti-inflammatory, antitumor, antiviral, hepatoprotective, antidiabetic, and antioxidant effects.
3
Ganoderma lucidum contains approximately 400 bioactive compounds, including triterpenoids, polysaccharides, nucleotides, sterols, proteins, peptides, and trace elements.
4
Ganoderma lucidum is recognized as a potential alternative adjuvant in treatments for leukemia, carcinoma, hepatitis, and diabetes.
5
The review examines Ganoderma lucidum cultivation methods, bioactive metabolites, and their roles in therapeutic applications.
Research Object
Ganoderma lucidum (Ling Zhi) macrofungus and its basidiocarps, mycelia, spores, and bioactive metabolites
Research Subject
The pharmacological effects, therapeutic applications, bioactive compounds, and cultivation of Ganoderma lucidum
Publication Details
Publication Date
2009-11-29
Journal
Current Pharmaceutical Biotechnology
Publisher
Bentham Science Publishers
ISSN
1389-2010
Cited by
531
Access Type
Author Information
Download PDF
Subscribe to digest